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Scar tactics for immunity
Although variola major (smallpox) was eradicated by vacci-
nation with the related orthopoxvirus vaccinia virus (VACV) 
via skin scarification (s.s.), researchers have begun to inves-
tigate the feasibility of renewed immunization strategies 
because of bioterrorism concerns. Liu and colleagues recently 
found that immunization via s.s. was required for the genera-
tion of superior protective immune responses to this virus. 
Indeed, the T-cell memory generated by recombinant VACV 
s.s. immun ization is necessary and sufficient for protection 
against cutaneous challenge with the virus. In addition, lethal 
respiratory challenge required VACV-specific mucosal effector 
memory cells as well as central memory T cells. These T cells 
were sufficient for protection even in the complete absence 
of an antibody response. Furthermore, nonreplicative modi-
fied vaccinia Ankara virus—a clinically safer virus for vaccine 
purposes—also yielded protection when administered via s.s. 
as compared with delivery via intramuscular injection. Thus, 
these results suggest a new method for the development of 
safe and effective VACV immunization protocols. (Nat Med 
16:224–7, 2010)
Dangers of transcription
UV radiation induces photolesions that block both DNA rep-
lication and transcription. Transcription of a gene increases its 
mutability by UV radiation in mouse embryonic stem cells. To 
examine the mechanism for transcription-associated mutagen-
esis (TAM), Hendriks and colleagues disrupted the Xpa gene, 
which is involved in global genome and transcription-coupled 
nucleotide excision repair (NER), and examined the impact of 
photolesions on the genome. In this system, UV lesions were 
more mutagenic upon transcription of the damaged template. 
In addition, these data revealed that NER protects transcribed 
genes from TAM. In particular, transcription enhanced cyto-
sine deamination at UV photolesions, and this transcription-
associated deamination of cytosines proved to be a critical 
intermediate in UV mutagenesis. This novel mechanism for 
UV radiation–induced mutagenesis offers an explanation for 
the role of transcription machinery in DNA damage sensing 
and provides insight into the molecular basis of UV radiation–
induced carcinogenesis. (Curr Biol 20:170–5, 2010)
Cytokine targets in candidiasis
Chronic mucocutaneous candidiasis (CMC) often occurs 
in immunodeficiencies, e.g., in HIV infection, and pro-
tection is thought to be mediated via T cells, particularly 
IL-17-producing T helper type 17 cells at epithelial surfaces. 
CMC is the earliest and most common sign of autoimmune 
polyendocrinopathy candidiasis ectodermal dystrophy 
(APECED, or autoimmune polyendocrine syndrome type I), 
an autosomal recessive syndrome caused by defects in the 
autoimmune regulator (AIRE) gene. These defects invoke auto-
immune responses that cause endocrine features of this dis-
ease; however, the immunodeficiencies that underlie CMC in 
APECED are not understood.
In two recent companion papers, Puel and colleagues and 
Kisand and colleagues examined IL-17 and IL-22 responses 
in the sera of APECED patients in order to probe the puzzling 
immunodeficiencies. These researchers detected significantly 
reduced IL-17F and IL-22 responses in patients with CMC, 
which suggest that these cytokines are involved in protec-
tion against CMC. Importantly, serum autoantibodies against 
IL-17A, IL-17F, and/or IL-22 were found in the majority of 
patients harboring AIRE mutations. Furthermore, these anti-
bodies occurred more frequently in APECED patients with 
CMC than in those without, imparting clinical significance 
to the presence of these autoantibodies. Indeed, the autoan-
tibodies were neutralizing in functional assays. In these sera, 
autoantibodies to other cytokines were not detected. On 
the basis of these observations, autoimmunity in APECED 
targets not only endocrine tissues but also components of 
the acquired immune system—specifically, IL-17A, IL-17F, 
and IL-22, which are involved in protection against CMC. 
As a result, immunosuppressive treatments and even IL-22 
replacement therapy may be novel approaches to treating 
CMC in the future. (J Exp Med 207:291–7, 2010; J Exp Med 
207:299–308, 2010)
Under the radar:  
bias in systematic reviews
Outcome reporting bias occurs when a subset of the orig-
inal recorded outcome variables is selected for publication 
on the basis of the results. To assess the impact of outcome 
reporting bias in randomized controlled trials on a cohort 
of systematic reviews, Kirkham and colleagues examined 
the prevalence of outcome reporting bias using a nine-
point classification system for missing outcome data in an 
unselected cohort of 283 Cochrane systematic reviews. 
Outcome reporting bias was suspected for at least one ran-
domized controlled trial in 34% of the systematic reviews 
examined. This value, however, is higher than the number 
of reviews that referenced the potential for such a bias; thus, 
the bias problem is clearly underrecognized. In addition, 
outcome reporting bias was shown to affect the treatment-
effect estimate in a considerable number of Cochrane 
reviews, which are considered among the best sources of 
reliable, up-to-date health-care information. These results 
affirm that trials should not be excluded because of a lack of 
relevant outcome data, and they support disclosure of ran-
domized controlled trials before initiation and the results of 
such trials after completion. (BMJ 340:c365, 2010)
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